The Next Generation of
Dermal Tissue Grafts is Here!
We aim to expedite tissue repair and rapidly achieve desired clinical outcomes using our proprietary graft microsurfacing technology.
CellTherX™ has developed and patented advanced technology to modify tissue grafts by strategically creating partial thickness cuts across at least one exterior surface. This microsurfacing process generates grafts that have significantly more surface area than standard grafts. Increased surface area can support profuse cell attachment and acute cell infiltration at the graft-host interface. These features may ultimately lead to rapid graft incorporation, neovascularization, remodeling and integration with the goal of yielding favorable functional and cosmetic outcomes as quickly as possible.
Currently, CellTherX™ is applying its proprietary microsurfacing technology to human acellular dermal matrix (ADM) grafts. Originating from the generous gift of tissue donation, ADMs are naturally-derived scaffolds that have a long and successful history of clinical use for applications such as soft tissue augmentation, skin grafting and wound care. Microsurfaced ADMs represent novel, next generation grafts that are distinctly differentiated from traditional versions and offer the potential to rapidly obtain intended clinical results.